January 2011 Newsletter

January 24, 2011:

Emerging Markets Drive 2010 Refractive Market Growth

In 2010, the refractive market remained under pressure in the US and other wealthy nations due to weakened economic conditions, but growing demand in emerging economies more than offset these declines.

January 24, 2011:

Growth in IOL Industry Driven by Premium Special-Purpose Lenses in 2010

Demand for PC-IOLs and other special purpose IOLs drove growth in the IOL industry during 2010.

January 24, 2011:

2010 IVT Injections Soar and Raise Troubling Questions

2010 saw rapid growth in the number of intravitreal injections, but the soaring volume magnified questions about the risks, the costs, and the sustainability of the trend.

January 24, 2011:

New Ophthalmic Devices Get FDA Nod in 2010

In 2010, seven ophthalmic devices achieved FDA regulatory approval and four important 510(k) clearances were granted.

January 24, 2011:

FDA Approves Seven Ophthalmic Drugs in 2010

The FDA approved seven ophthalmic drugs for commercialization in the US.

January 24, 2011:

Despite the Economy, 2010 Was a Big Year for Funding Ophthalmic Ventures

Eleven ophthalmic firms developing products received venture-capital infusions during 2010.

January 24, 2011:

January 2011 News Briefs

This month's news briefs include news from Alimera Sciences, Alcon, Novartis, Bausch & Lomb, TrueVision 3D Surgical, Advanced Cell Technology, Inc., and New Leaf Venture Partners.

Social media